Tethering lentiviral restriction to Fc-mediated antibody responses
将慢病毒限制与 Fc 介导的抗体反应结合起来
基本信息
- 批准号:10425358
- 负责人:
- 金额:$ 70.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAddressAffectAlanineAmino Acid SequenceAmino AcidsAnimal ModelAnimalsAnti-Retroviral AgentsAntibodiesAntibody ResponseAntibody TherapyBindingCD4 Positive T LymphocytesCell LineCell surfaceCellsDevelopmentDoxycyclineDrug DesignEngineeringEpitopesFc domainHIVHIV-1HIV-2HumanImmunologicsInfectionIntegral Membrane ProteinInterferonsIntravenous infusion proceduresLinkMacacaMacaca mulattaMediatingMutationNatural ImmunityPathogenesisPhagocytesPhagocytosisPositioning AttributePredispositionProteinsResistanceSIVSerineSpecificitySurfaceTestingTherapeuticUp-RegulationVaccinesViralViral GenomeViral Load resultViral PathogenesisVirionVirusVirus DiseasesVirus Replicationadaptive immunityantagonistantibody testantibody-dependent cell cytotoxicityantibody-dependent cellular phagocytosiscombatexperimental studyimprovedin vivoinducible gene expressioninsightmacrophagemutantnef Genesnef Proteinneutrophilnonhuman primatenovelpreventreceptorreceptor bindingsynergismuptakevirus envelope
项目摘要
PROJECT SUMMARY
Tetherin, also known as BST-2 or CD317, is an interferon-inducible transmembrane protein that inhibits the
detachment of enveloped viruses from infected cells. Under conditions of interferon-induction, tetherin is
upregulated on virus-infected cells and captures nascent virions as they attempt to bud from the cell surface.
Whereas most simian immunodeficiency viruses (SIVs) use Nef to oppose the tetherin proteins of their
nonhuman primate hosts, HIV-1 Vpu and HIV-2 Env have acquired the ability to counteract human tetherin
because of the absence of a five amino acid sequence in human tetherin that confers susceptibility to Nef. We
previously demonstrated that tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent
cellular cytotoxicity (ADCC). We now show that the anti-tetherin activity of Vpu also protects HIV-infected cells
from antibody-dependent cellular phagocytosis (ADCP). These findings imply that by trapping virions on the
cell surface, tetherin increases the sensitivity of HIV-infected cells to Fc-mediated antibody responses, and that
the antiviral activity of tetherin may be much greater in vivo than previously appreciated. The current proposal
builds on these studies to address the overarching hypothesis that tetherin serves as link between innate and
adaptive immunity to enhance the susceptibility of virus-infected cells to antibodies.
In Aim 1, we will determine the immunological mechanisms by which tetherin enhances antibody-mediated
phagocytosis of HIV-infected cells. These studies will focus on the factors that influence the extent to which
tetherin can promote ADCP, which will provide a better understanding of how to use these interactions to
improve antibody-based treatments for HIV-1 infection. In Aim 2, we will take advantage of the power of SIV
infection of the rhesus macaque as an animal model to assess the contribution of viral countermeasures to
tetherin and SERINC5 to lentiviral replication and pathogenesis. These studies will reveal the impact of tetherin
and SERINC5 on lentiviral infection and the therapeutic benefit that may be derived from antiretroviral drugs
designed to increase the sensitivity of HIV-1 to these restriction factors. In Aim 3, we will test the hypothesis
that tetherin enhances antibody-mediated control of virus replication in SIV-infected macaques. These studies
are fundamental to our basic understanding of the synergy between tetherin and antibodies and the potential to
exploit these interactions for the treatment and prevention of HIV-1 infection.
项目总结
Tetherin,也被称为BST-2或CD317,是一种干扰素诱导的跨膜蛋白,它抑制
从受感染的细胞中分离被包裹的病毒。在干扰素诱导条件下,Tetherin是
在感染病毒的细胞上表达上调,并在新生病毒粒子试图从细胞表面发芽时捕获它们。
而大多数猴免疫缺陷病毒(SIV)使用Nef来对抗其
非人灵长类宿主HIV-1 VPU和HIV-2 Env已经获得了对抗人类系链的能力
因为人类Tetherin中没有五个氨基酸序列,这使人对Nef易感。我们
先前证明VPU的Tetherin拮抗作用保护HIV感染细胞免受抗体依赖
细胞毒性(ADCC)。我们现在表明,VPU的抗栓蛋白活性也保护了艾滋病毒感染的细胞。
来自抗体依赖的细胞吞噬作用(ADCP)。这些发现表明,通过将病毒粒子捕获在
在细胞表面,Tetherin增加了HIV感染细胞对Fc介导的抗体反应的敏感性,并且
Tetherin在体内的抗病毒活性可能比之前所认识的要强得多。目前的提案
建立在这些研究的基础上,以解决最重要的假设,即Tetherin在先天和
适应性免疫,以增强病毒感染细胞对抗体的敏感性。
在目标1中,我们将确定Tetherin增强抗体介导的免疫学机制。
HIV感染细胞的吞噬作用。这些研究将集中于影响以下因素的程度
Tetherin可以促进ADCP,这将提供对如何使用这些交互作用的更好理解
改进HIV-1感染的基于抗体的治疗。在目标2中,我们将利用SIV的力量
以恒河猴感染为动物模型评估病毒对策的贡献
Tetherin和SERINC5与慢病毒复制和发病机制的关系。这些研究将揭示系留的影响
和SERINC5对慢病毒感染的作用以及抗逆转录病毒药物可能产生的治疗益处
旨在提高HIV-1对这些限制因素的敏感性。在目标3中,我们将检验假设
这种Tetherin增强了抗体介导的对SIV感染猕猴病毒复制的控制。这些研究
对于我们基本理解Tetherin和抗体之间的协同作用以及潜在的
利用这些相互作用来治疗和预防艾滋病毒-1感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David T Evans其他文献
David T Evans的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David T Evans', 18)}}的其他基金
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
双脱氢皮质抑素 A 作为阻断剂在猕猴模型中功能性 HIV 治愈的评价
- 批准号:
10403162 - 财政年份:2021
- 资助金额:
$ 70.77万 - 项目类别:
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
双脱氢皮质抑素 A 作为阻断剂在猕猴模型中功能性 HIV 治愈的评价
- 批准号:
10591883 - 财政年份:2021
- 资助金额:
$ 70.77万 - 项目类别:
Tethering lentiviral restriction to Fc-mediated antibody responses
将慢病毒限制与 Fc 介导的抗体反应结合起来
- 批准号:
10082732 - 财政年份:2020
- 资助金额:
$ 70.77万 - 项目类别:
Tethering lentiviral restriction to Fc-mediated antibody responses
将慢病毒限制与 Fc 介导的抗体反应结合起来
- 批准号:
10203816 - 财政年份:2020
- 资助金额:
$ 70.77万 - 项目类别:
Tethering lentiviral restriction to Fc-mediated antibody responses
将慢病毒限制与 Fc 介导的抗体反应结合起来
- 批准号:
10661036 - 财政年份:2020
- 资助金额:
$ 70.77万 - 项目类别:
Assessing ADCC and Fc-mediated Protection against HIV
评估 ADCC 和 Fc 介导的 HIV 保护作用
- 批准号:
10671615 - 财政年份:2019
- 资助金额:
$ 70.77万 - 项目类别:
Assessing ADCC and Fc-mediated Protection against HIV
评估 ADCC 和 Fc 介导的 HIV 保护作用
- 批准号:
10808458 - 财政年份:2019
- 资助金额:
$ 70.77万 - 项目类别:
Assessing ADCC and Fc-mediated Protection against HIV
评估 ADCC 和 Fc 介导的 HIV 保护作用
- 批准号:
10226317 - 财政年份:2019
- 资助金额:
$ 70.77万 - 项目类别:
Assessing ADCC and Fc-mediated Protection against HIV
评估 ADCC 和 Fc 介导的 HIV 保护作用
- 批准号:
10458659 - 财政年份:2019
- 资助金额:
$ 70.77万 - 项目类别:
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
Fcγ受体介导的免疫缺陷病毒复制抑制
- 批准号:
9275920 - 财政年份:2015
- 资助金额:
$ 70.77万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 70.77万 - 项目类别:
Research Grant














{{item.name}}会员




